Pretax income is the income that a company earns before paying income taxes. AEON Biopharma's pretax income for the
three
months ended in Mar. 2024 was $-118.02 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-118.02 Mil.
AEON Biopharma's pretax margin was %.
During the past 5 years, AEON Biopharma's highest Pretax Margin was 4339.29%. The lowest was -1307.11%. And the median was 1516.09%.
AEON Biopharma Pre-Tax Income Historical Data
The historical data trend for AEON Biopharma's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of AEON Biopharma's Pre-Tax Income
For the Biotechnology subindustry, AEON Biopharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AEON Biopharma's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, AEON Biopharma's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where AEON Biopharma's Pre-Tax Income falls into.
AEON Biopharma Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
AEON Biopharma's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-118.02 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AEON Biopharma (AMEX:AEON) Pre-Tax Income Explanation
AEON Biopharma's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as
During the past 5 years, AEON Biopharma's highest Pretax Margin was 4339.29%. The lowest was -1307.11%. And the median was 1516.09%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AEON Biopharma Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of AEON Biopharma's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
AEON Biopharma (AEON Biopharma) Business Description
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for therapeutic indications.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AEON has been successfully added to your 